A survey on the current trends in the management of hepatitis B in China

European Journal of Gastroenterology and Hepatology

Volumn 24, Issue 8, 2012, Pages 884-889

  Ning, Lin Hong ^a   Hao, Jia ^a   Liao, Zhong Li ^a   Zhou, Yuan Yuan ^a   Guo, Hong ^a   Zhao, Xiao Yan ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

antiviral treatment; chronic hepatitis B; hepatitis B virus drugs resistance; interferon; management; nucleoside analogues

Indexed keywords

ADEFOVIR DIPIVOXIL; ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; ANTIVIRUS AGENT; ENTECAVIR; HEPATITIS B(E) ANTIGEN; INTERFERON; LAMIVUDINE; PEGINTERFERON; TELBIVUDINE; TENOFOVIR; VIRUS DNA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBIOTIC PROPHYLAXIS; ANTIVIRAL THERAPY; ARTICLE; CHINA; HEALTH SURVEY; HEPATITIS B; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; MEDICAL CARE; MEDICAL SPECIALIST; PHYSICIAN; PRIORITY JOURNAL; TREND STUDY; UNIVERSITY HOSPITAL;

ANTIVIRAL AGENTS; CHINA; DATA COLLECTION; DNA, VIRAL; DRUG RESISTANCE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SURVEYS; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HOSPITALS, TEACHING; HUMANS; INTERFERONS; QUESTIONNAIRES;

EID: 84864052429     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32835447fa     Document Type: Article

References (15)

1. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment,and current and emerging prevention and control measures. Viral Hepat 2004; 11:97-107.
2. Liaw YF. Antiviral therapy of chronic hepatitis B: Opportunities and hallenges in Asia. Hepatology 2009; 51:403-410.
3. De Franchis R, Hadengue A, Lau G, Lavanchy D, Lok A, McIntyre N, et al. EASL International Consensus Conference on Hepatitis B. J Hepatol 2003; 39:S3-S25.
4. Lok ASF, McMahon BJ. Chronic hepatitis B. Hepatology 2007; 45: 507-539.
5. Hoofnagle JH, Doo E, Liang TJ, Fleischer R, Lok AS. Management of hepatitis B: Summary of a clinical research. Hepatology 2007; 45: 1056-1075.
6. Les I, García-Martínez R, Có rdoba J, Quintana M, Esteban R, Buti M. Current trends in chronic hepatitis B management: Results of a questionnaire. Hepatology 2009; 21:1177-1183.
7. Papatheodoridis GV, Manolakopoulos S, Dusheiko G, Archimandritis AJ. Therapeutic strategies in the management of patients with chronic hepatitisB. Lancet Infect Dis 2008; 8:167-178.
8. European Association for the Study of the Liver. EASL clinical practice guidelines: Management of chronic hepatitis B. Hepatol 2009; 50: 227-242.
9. Keeffe EB, Dieterich DT, Han SH, Jacobson IM, Martin P, Schiff ER, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: An update. Clin Gastroenterol Hepatol 2006; 4: 936-962.
10. Liaw YF, Leung N, Guan R, Lau GK, Merican I, McCaughan G, et al. Asian-pacific consensus statement on the management of chronic hepatitis B: A 2005 update. Liver Int 2005; 25:472-489.
11. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: Epidemiology and vaccination. Epidemiol Rev 2006; 28:112-125.
12. Lu Feng-min, Zhuang Hui. Prevention of hepatitis B in China: Achievements and challenges. Chin Med J 2009; 122:2925-2927.
13. Jinlin Hou, Zhihua Liu, Fan Gu. Epidemiology and Prevention of Hepatitis B Virus Infection. Int J Med Sci 2005; 2:50-57.
14. Liang X, Bi S, Yang W, Wang L, Wang L, Cui G, Cui F. Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China. Infect Dis 2009; 200:39-47.
15. Sánchez-Quijano A, Lissen E. Treatment of viral hepatitis (I). Treatment of chronic hepatitis B. Enferm Infecc Microbiol Clin 2006; 24: 453-461.